Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Nov 21, 2022
Date Accepted: Feb 28, 2023
Date Submitted to PubMed: Mar 6, 2023

The final, peer-reviewed published version of this preprint can be found here:

Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit

Argyropoulos CD, Leckler J, Salmanton-García J, Constantinou M, Alexandrou A, Themistocleous S, Noula E, Shiamakkides G, Nearchou A, Stewart FA, Albus K, Koniordou M, Kopsidas I, Spivak O, Hellemans M, Hendrickx G, Davis RJ, Azzini AM, Valle-Simón P, Carcas AJ, Askling HH, Vene S, Prellezo JB, Álvarez-Barco E, Macken A, Di Marzo R, Luís C, Olesen OF, Frias-Iniesta J, Barta I, Toth K, Akova M, Bonten MM, Cohen-Kandli M, Cox RJ, Součková L, Husa P, Jancoriene L, Launay O, Lundgren J, Mallon P, Mendonça MA, Marques L, Nauclér P, Ochando J, Tacconelli E, van Damme P, Zaoutis TE, Hofstraat SHI, Bruijning P, Zeitlinger M, Cornely OA, Pana ZD

Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit

JMIR Public Health Surveill 2023;9:e44491

DOI: 10.2196/44491

PMID: 36878478

PMCID: 10131613

Enhancing public health communication of vaccine trials: The pan-European VACCELERATE Toolkit

  • Christos D. Argyropoulos; 
  • Janina Leckler; 
  • Jon Salmanton-García; 
  • Marinos Constantinou; 
  • Alexandra Alexandrou; 
  • Sophia Themistocleous; 
  • Evgenia Noula; 
  • George Shiamakkides; 
  • Andria Nearchou; 
  • Fiona A. Stewart; 
  • Kerstin Albus; 
  • Markela Koniordou; 
  • Ioannis Kopsidas; 
  • Orly Spivak; 
  • Margot Hellemans; 
  • Greet Hendrickx; 
  • Ruth Joanna Davis; 
  • Anna Maria Azzini; 
  • Paula Valle-Simón; 
  • Antonio J. Carcas; 
  • Helena H. Askling; 
  • Sirkka Vene; 
  • Jana Baranda Prellezo; 
  • Elena Álvarez-Barco; 
  • Alan Macken; 
  • Romina Di Marzo; 
  • Catarina Luís; 
  • Ole F. Olesen; 
  • Jesus Frias-Iniesta; 
  • Imre Barta; 
  • Kristina Toth; 
  • Murat Akova; 
  • Marc M.J. Bonten; 
  • Miriam Cohen-Kandli; 
  • Rebecca Jane Cox; 
  • Lenka Součková; 
  • Petr Husa; 
  • Ligita Jancoriene; 
  • Odile Launay; 
  • Jens Lundgren; 
  • Patrick Mallon; 
  • Maria Amélia Mendonça; 
  • Laura Marques; 
  • Pontus Nauclér; 
  • Jordi Ochando; 
  • Evelina Tacconelli; 
  • Pierre van Damme; 
  • Theoklis E. Zaoutis; 
  • Sanne H. I. Hofstraat; 
  • Patricia Bruijning; 
  • Markus Zeitlinger; 
  • Oliver A. Cornely; 
  • Zoi Dorothea Pana

ABSTRACT

Background:

The present work exhibits a set of harmonised vaccine trial educational and promotional tools for the general public, designed and disseminated by the pan-European VACCELERATE network.

Objective:

The main objective is to raise awareness of vaccine trial participation in the general population, but also to increase the information accessibility to trustful sources regarding vaccine trials.

Methods:

The tools’ development has followed the aims and principles of the VACCELERATE project, focusing on trial inclusiveness and equity and they are adjusted to the local country requirements to improve public health communication.

Results:

The educational material provides the European Union’s (EU) general public with fundamental knowledge about vaccine clinical research, as well as informs the public about possible benefits and disadvantages of trial participation.

Conclusions:

The produced material could also be useful for filling knowledge gaps of healthcare personnel and providing the appropriate future patient education for vaccine trials, as well as to tackle vaccine hesitancy and parents’ concerns for potential participation of children in vaccine trials.


 Citation

Please cite as:

Argyropoulos CD, Leckler J, Salmanton-García J, Constantinou M, Alexandrou A, Themistocleous S, Noula E, Shiamakkides G, Nearchou A, Stewart FA, Albus K, Koniordou M, Kopsidas I, Spivak O, Hellemans M, Hendrickx G, Davis RJ, Azzini AM, Valle-Simón P, Carcas AJ, Askling HH, Vene S, Prellezo JB, Álvarez-Barco E, Macken A, Di Marzo R, Luís C, Olesen OF, Frias-Iniesta J, Barta I, Toth K, Akova M, Bonten MM, Cohen-Kandli M, Cox RJ, Součková L, Husa P, Jancoriene L, Launay O, Lundgren J, Mallon P, Mendonça MA, Marques L, Nauclér P, Ochando J, Tacconelli E, van Damme P, Zaoutis TE, Hofstraat SHI, Bruijning P, Zeitlinger M, Cornely OA, Pana ZD

Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit

JMIR Public Health Surveill 2023;9:e44491

DOI: 10.2196/44491

PMID: 36878478

PMCID: 10131613

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.